regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immunoseerumit ja immunoglobuliinit, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanooma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.